1 row is stored for this page
| Field | Field type | Value |
|---|
| generic | String | Allopurinol |
| brand | String | Zyloprim, Aloprim (IV) |
| structure | File | |
| classes | List of String, delimiter: , | [[:Category:Xanthine_oxidase_inhibitors|Xanthine oxidase inhibitor]] • [[:Category:Antihyperuricemic_agents|Antihyperuricemic agent]] • [[:Category:Antigout_agents|Antigout agent]] |
| mechanism | String | |
| uses | String | '"`UNIQ--vote-0000030B-QINU`"', '"`UNIQ--vote-0000030C-QINU`"', '"`UNIQ--vote-0000030D-QINU`"', '"`UNIQ--vote-0000030E-QINU`"' |
| starting_dose | String | 100 mg PO once daily; titrate by 100 mg every 2-4 weeks to a serum urate target (typically <6 mg/dL, or <5 in tophaceous disease) |
| preparations | String | 100 mg, 300 mg tablets; IV 500 mg vial |
| fda_max | String | 800 mg/d (rarely needed) |
| pill_id | Text | |
| routes | List of String, delimiter: , | Oral • IV |
| onset | String | Serum urate falls gradually over days to weeks; acute flare prevention requires colchicine cover during initiation |
| duration | String | 24 hours |
| halflife | String | 1-2 hours (parent); 18-30 hours for active metabolite oxypurinol'"`UNIQ--ref-0000030F-QINU`"' |
| bioavailability | String | ~80% (oral)'"`UNIQ--ref-00000310-QINU`"' |
| pregnancy | String | Limited safety data; weigh benefit individually.<sup class="pcp-cn" title="This claim needs a citation.">[[[Pharmacopedia:Citation needed|citation needed]]]</sup> |
| legal | String | [[USLegal:Prescription only|Rx-only]] in US |
